Our Work

HBHI convened supply chain scholars and industry leaders to discuss how to prevent supply chain interruptions from occurring when the next pandemic invariably arrives.

A symposium co-hosted by HBHI and the Hopkins Economics of Alzheimer's Disease and Services Center covers the ramifications of the approval of controversial Alzheimer's Disease drug Aduhelm for patients enrolled in approved clinical trials.

James Zou, PhD, Associate Professor of Biomedical Data Science, Chan-Zuckerberg investigator, and Sloan Fellow, Stanford University